Last reviewed · How we verify

NCT03951948: Optihip

Optimys Femoral Stem for Total Hip Replacement

Completed Last updated 15 June 2021
What this trial tests

trial testing retrospective analysis of surgical performance, clinical and radiologic outcome in Short Stem Prosthesis in 453 participants. Completed in 9 June 2021.

Timeline
16 April 2019
Primary endpoint
9 June 2021
9 June 2021

Quick facts

Lead sponsorUniversity Hospital, Basel, Switzerland
StatusCompleted
Study typeOBSERVATIONAL
Enrollment453
Start date16 April 2019
Primary completion9 June 2021
Estimated completion9 June 2021
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Basel, Switzerland

Who can join

18 and older, any sex, with Short Stem Prosthesis or Optimys Femoral Stem. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This retrospective observational study analyses the surgical performance, clinical and radiologic outcome as well as the rate of infections with a main focus on revision surgeries after primary implantation of the Optimys short stem femoral prosthesis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Basel, Switzerland trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03951948.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing